Ed Sgeridan

quality assurance documentation and training specialist at Rubius Therapeutics - Cambridge, Massachusetts, US

Ed Sgeridan's Colleagues at Rubius Therapeutics
Michelle Beauchemin

Manager, Quality Control Stability, Sample Management and Raw Materials

Contact Michelle Beauchemin

Gary Sostak

Maintenance Technician

Contact Gary Sostak

Kunza Ahmad

Translational Research Associate

Contact Kunza Ahmad

Dennis Douglas

Senior Manufacturing Technician

Contact Dennis Douglas

Tracey Pakstis

contract and patent administrator

Contact Tracey Pakstis

View All Ed Sgeridan's Colleagues
Ed Sgeridan's Contact Details
HQ
(617) 679-9600
Location
Company
Rubius Therapeutics
Ed Sgeridan's Company Details

Rubius Therapeutics

Cambridge, Massachusetts, US • 250 - 499 Employees
BioTech/Drugs

Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.

Rubius Therapeutics Rubius Red Platform Rubius Rubius Therapeutics Pitch Deck Rubius Thera
Details about Rubius Therapeutics
Frequently Asked Questions about Ed Sgeridan
Ed Sgeridan currently works for Rubius Therapeutics.
Ed Sgeridan's role at Rubius Therapeutics is quality assurance documentation and training specialist.
Ed Sgeridan's email address is ***@rubiustx.com. To view Ed Sgeridan's full email address, please signup to ConnectPlex.
Ed Sgeridan works in the BioTech/Drugs industry.
Ed Sgeridan's colleagues at Rubius Therapeutics are Michelle Beauchemin, Gary Sostak, Kunza Ahmad, Dennis Douglas, Alex Nanna, Tracey Pakstis, Xuqing Zhang and others.
Ed Sgeridan's phone number is ["+14012196500"]
See more information about Ed Sgeridan